Article Details

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Retrieved on: 2021-07-29 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology. View article details on HISWAI: https://www.dovepress.com/ocrelizumab-for-the-treatment-of-multiple-sclerosis-safety-efficacy-an-peer-reviewed-fulltext-article-TCRM

Excerpt

Ocrelizumab, a humanized monoclonal antibody that selectively targets CD20+ B-cells, profoundly suppresses acute inflammatory disease activity, ...

Article found on: www.dovepress.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up